ArticleScience advances2026

SIK2 antagonizes postinfarction cardiac repair by driving macrophage proinflammatory and impairing efferocytosis.

Wu-Wei Rong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.